首页 >
法规速递
-
Document: List of signals discussed at PRAC since September 2012-2026/7/6
2026-07-07查看详情 > -
Document: Start of procedure: Type II Variation - Extension of indication under evaluation by the CHMP (22 May 2026 - 25 June 2026)-2026/7/6
2026-07-07查看详情 > -
Document: Start of procedure: Extension of marketing authorisation (22 May 2026 - 25 June 2026)-2026/7/6
2026-07-07查看详情 > -
Document: New product information wording: extracts from PRAC recommendations on signals adopted at the 8-11 June 2026 PRAC-2026/7/6
2026-07-07查看详情 > -
Document: PRAC recommendations on signals adopted at the 8-11 June 2026 PRAC meeting-2026/7/6
2026-07-07查看详情 > -
Page: Variations requiring assessment (veterinary medicines)-2026/7/3
2026-07-06查看详情 > -
Document: List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment-2026/7/3
2026-07-06查看详情 > -
Page: Combination Products Operational Group: agendas and highlight reports-2026/7/3
2026-07-06查看详情 > -
Document: Medicine shortage communication (MSC): TEGSEDI® (inotersen sodium, 284 mg solution for injection in prefilled syringe): planned marketing cessation (discontinuation)-2026/7/3
2026-07-06查看详情 > -
Document: Declaration of interests: Silvy da Rocha Dias-2026/7/2
2026-07-03查看详情 >
